Neuroimaging and cognition in parkinson's disease dementia

Brain Pathology

Volumn 20, Issue 3, 2010, Pages 646-653

  Silbert, Lisa C ^a   Kaye, Jeffrey ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Cognition; Dementia; Magnetic resonance imaging (MRI); Neuroimaging; Parkinson's Disease

Indexed keywords

ACETYLCHOLINE; DOPAMINE; PITTSBURGH COMPOUND B;

ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; BRAIN ATROPHY; BRAIN METABOLISM; BRAIN PERFUSION; BRAIN SIZE; CHOLINERGIC TRANSMISSION; COGNITIVE DEFECT; CONFERENCE PAPER; DEMENTIA; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; DIFFUSION TENSOR IMAGING; DOPAMINERGIC SYSTEM; HIPPOCAMPUS; HUMAN; MILD COGNITIVE IMPAIRMENT; MOLECULAR IMAGING; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PREDICTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; WHITE MATTER;

COGNITION DISORDERS; DIAGNOSTIC IMAGING; HUMANS; PARKINSON DISEASE;

EID: 77950839159     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2009.00368.x     Document Type: Conference Paper

References (74)

1. Aarsland D, Beyer MK, Kurz MW (2008) Dementia in Parkinson's disease. Curr Opin Neurol 21 : 676 682.
2. Abe Y, Kachi T, Kato T, Arahata Y, Yamada T, Washimi Y et al (2003) Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing. J Neurol Neurosurg Psychiatry 74 : 419 422.
3. Antonini A, De Notaris R, Benti R, De Gaspari D, Pezzoli G (2001) Perfusion ECD/SPECT in the characterization of cognitive deficits in Parkinson's disease. Neurol Sci 22 : 45 46.
4. Arendt T, Bigl V, Arendt A, Tennstedt A (1983) Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease. Acta Neuropathol (Berl) 61 : 101 108.
5. Beyer MK, Aarsland D (2008) Grey matter atrophy in early versus late dementia in Parkinson's disease. Parkinsonism Relat Disord 14 : 620 625.
6. Beyer MK, Janvin CC, Larsen JP, Aarsland D (2007) A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry. J Neurol Neurosurg Psychiatry 78 : 254 259.
7. Bohnen NI, Kaufer DI, Hendrickson R, Ivanco LS, Lopresti BJ, Constantine GM et al (2006) Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia. J Neurol 253 : 242 247.
8. Bohnen NI, Kaufer DI, Ivanco LS, Lopresti B, Koeppe RA, Davis JG et al (2003) Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Arch Neurol 60 : 1745 1748.
9. Bosboom JL, Stoffers D, Wolters E (2004) Cognitive dysfunction and dementia in Parkinson's disease. J Neural Transm 111 : 1303 1315. (Pubitemid 39468392)
10. Bouchard TP, Malykhin N, Martin WR, Hanstock CC, Emery DJ, Fisher NJ, Camicioli RM (2008) Age and dementia-associated atrophy predominates in the hippocampal head and amygdala in Parkinson's disease. Neurobiol Aging 29 : 1027 1039.
11. Bozzali M, Falini A, Cercignani M, Baglio F, Farina E, Alberoni M et al (2005) Brain tissue damage in dementia with Lewy bodies: an in vivo diffusion tensor MRI study. Brain 128 (Pt 7 1595 1604.
12. Broussolle E, Dentresangle C, Landais P, Garcia-Larrea L, Pollak P, Croisile B et al (1999) The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson's disease. J Neurol Sci 166 : 141 151.
13. Bruck A, Aalto S, Nurmi E, Bergman J, Rinne JO (2005) Cortical 6-[18F]fluoro-L-dopa uptake and frontal cognitive functions in early Parkinson's disease. Neurobiol Aging 26 : 891 898.
14. Bruck A, Kurki T, Kaasinen V, Vahlberg T, Rinne JO (2004) Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson's disease is related to cognitive impairment. J Neurol Neurosurg Psychiatry 75 : 1467 1469.
15. Bruck A, Portin R, Lindell A, Laihinen A, Bergman J, Haaparanta M et al (2001) Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus. Neurosci Lett 311 : 81 84.
16. Burton EJ, McKeith IG, Burn DJ, O'Brien JT (2005) Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging. Mov Disord 20 : 1571 1576.
17. Burton EJ, McKeith IG, Burn DJ, Williams ED, O'Brien JT (2004) Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 127 (Pt 4 791 800.
18. Camicioli R, Moore MM, Kinney A, Corbridge E, Glassberg K, Kaye JA (2003) Parkinson's disease is associated with hippocampal atrophy. Mov Disord 18 : 784 790.
19. Churchyard A, Lees AJ (1997) The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson's disease.[see comment]. Neurology 49 : 1570 1576.
20. Colloby SJ, Pakrasi S, Firbank MJ, Perry EK, Piggott MA, Owens J et al (2006) In vivo SPECT imaging of muscarinic acetylcholine receptors using (R,R) 123I-QNB in dementia with Lewy bodies and Parkinson's disease dementia. Neuroimage 33 : 423 429.
21. Colloby SJ, Williams ED, Burn DJ, Lloyd JJ, McKeith IG, O'Brien JT (2005) Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT. Eur J Nucl Med Mol Imaging 32 : 1176 1185.
22. de la Monte SM, Wells SE, Hedley-Whyte T, Growdon JH (1989) Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease.[see comment]. Ann Neurol 26 : 309 320.
23. Edison P, Rowe CC, Rinne JO, Ng S, Ahmed I, Kemppainen N et al (2008) Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. J Neurol Neurosurg Psychiatry 79 : 1331 1338.
24. Felicio AC, Shih MC, Godeiro-Junior C, Andrade LA, Bressan RA, Ferraz HB (2009) Molecular imaging studies in Parkinson disease: reducing diagnostic uncertainty. Neurolog 15 : 6 16.
25. Firbank MJ, Blamire AM, Krishnan MS, Teodorczuk A, English P, Gholkar A et al (2007) Diffusion tensor imaging in dementia with Lewy bodies and Alzheimer's disease. Psychiatry Res 155 : 135 145.
26. Firbank MJ, Colloby SJ, Burn DJ, McKeith IG, O'Brien JT (2003) Regional cerebral blood flow in Parkinson's disease with and without dementia. Neuroimage 20 : 1309 1319.
27. Gomperts SN, Rentz DM, Moran E, Becker JA, Locascio JJ, Klunk WE et al (2008) Imaging amyloid deposition in Lewy body diseases. Neurology 71 : 903 910.
28. Harding AJ, Stimson E, Henderson JM, Halliday GM (2002) Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease. Brain 125 (Pt 11 2431 2445.
29. Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 23 : 837 844.
30. Hilker R, Thomas AV, Klein JC, Weisenbach S, Kalbe E, Burghaus L et al (2005) Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways. Neurology 65 : 1716 1722.
31. Holthoff-Detto VA, Kessler J, Herholz K, Bonner H, Pietrzyk U, Wurker M et al (1997) Functional effects of striatal dysfunction in Parkinson disease. Arch Neurol 54 : 145 150.
32. Hu MT, Taylor-Robinson SD, Chaudhuri KR, Bell JD, Labbe C, Cunningham VJ et al (2000) Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study. Brain 123 (Pt 2 340 352.
33. Hu MT, White SJ, Chaudhuri KR, Morris RG, Bydder GM, Brooks DJ (2001) Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline. J Neural Transm 108 : 571 580.
34. Huang C, Mattis P, Perrine K, Brown N, Dhawan V, Eidelberg D (2008) Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease. Neurology 70 (16 Pt 2 1470 1477.
35. Huang C, Mattis P, Tang C, Perrine K, Carbon M, Eidelberg D (2007) Metabolic brain networks associated with cognitive function in Parkinson's disease. Neuroimage 34 : 714 723.
36. Huang C, Tang C, Feigin A, Lesser M, Ma Y, Pourfar M et al (2007) Changes in network activity with the progression of Parkinson's disease. Brain 130 (Pt 7 1834 1846. (Pubitemid 47343798)
37. Ibarretxe-Bilbao N, Ramirez-Ruiz B, Tolosa E, Marti MJ, Valldeoriola F, Bargallo N, Junque C (2008) Hippocampal head atrophy predominance in Parkinson's disease with hallucinations and with dementia. J Neurol 255 : 1324 1331.
38. Ito K, Nagano-Saito A, Kato T, Arahata Y, Nakamura A, Kawasumi Y et al (2002) Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: a 6-[18F]fluoro-L-dopa PET study. Brain 125 (Pt 6 1358 1365.
39. Jagust WJ, Reed BR, Martin EM, Eberling JL, Nelson-Abbott RA (1992) Cognitive function and regional cerebral blood flow in Parkinson's disease. Brain 115 (Pt 2 521 537.
40. Jokinen P, Bruck A, Aalto S, Forsback S, Parkkola R, Rinne JO (2009) Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy. Parkinsonism Relat Disord 15 : 88 93.
41. Junque C, Ramirez-Ruiz B, Tolosa E, Summerfield C, Marti MJ, Pastor P et al (2005) Amygdalar and hippocampal MRI volumetric reductions in Parkinson's disease with dementia. Mov Disord 20 : 540 544.
42. Karagulle Kendi AT, Lehericy S, Luciana M, Ugurbil K, Tuite P (2008) Altered diffusion in the frontal lobe in Parkinson disease. AJNR Am J Neuroradiol 29 : 501 505.
43. Kasama S, Tachibana H, Kawabata K, Yoshikawa H (2005) Cerebral blood flow in Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease according to three-dimensional stereotactic surface projection imaging. Dement Geriatr Cogn Disord 19 : 266 275.
44. Kuhl DE, Metter EJ, Riege WH (1984) Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method. Ann Neurol 15 : 419 424.
45. Laakso MP, Partanen K, Riekkinen P, Lehtovirta M, Helkala EL, Hallikainen M et al (1996) Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: an MRI study. Neurology 46 : 678 681.
46. Lozza C, Baron JC, Eidelberg D, Mentis MJ, Carbon M, Marie RM (2004) Executive processes in Parkinson's disease: FDG-PET and network analysis. Hum Brain Mapp 22 : 236 245.
47. Maetzler W, Reimold M, Liepelt I, Solbach C, Leyhe T, Schweitzer K et al (2008) [11C]PIB binding in Parkinson's disease dementia. Neuroimage 39 : 1027 1033.
48. Mahler ME, Cummings JL (1990) Alzheimer disease and the dementia of Parkinson disease: comparative investigations. Alzheimer Dis Assoc Disord 4 : 133 149.
49. Marie RM, Barre L, Dupuy B, Viader F, Defer G, Baron JC (1999) Relationships between striatal dopamine denervation and frontal executive tests in Parkinson's disease. Neurosci Lett 260 : 77 80.
50. Matsui H, Nishinaka K, Oda M, Niikawa H, Kubori T, Udaka F (2007) Dementia in Parkinson's disease: diffusion tensor imaging. Acta Neurol Scand 116 : 177 181. (Pubitemid 47262765)
51. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65 : 1863 1872.
52. Mentis MJ, McIntosh AR, Perrine K, Dhawan V, Berlin B, Feigin A et al (2002) Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease. Am J Psychiatry 159 : 746 754.
53. Meyer JS, Huang J, Chowdhury MH (2007) MRI confirms mild cognitive impairments prodromal for Alzheimer's, vascular and Parkinson-Lewy body dementias. J Neurol Sci 257 : 97 104.
54. Muller U, Wachter T, Barthel H, Reuter M, von Cramon DY (2000) Striatal [123I]beta-CIT SPECT and prefrontal cognitive functions in Parkinson's disease. J Neural Transm 107 : 303 319.
55. Muslimovic D, Post B, Speelman JD, Schmand B (2005) Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 65 : 1239 1245.
56. Nagano-Saito A, Washimi Y, Arahata Y, Kachi T, Lerch JP, Evans AC et al (2005) Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology 64 : 224 229.
57. O'Brien JT, Colloby S, Fenwick J, Williams ED, Firbank M, Burn D et al (2004) Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol 61 : 919 925.
58. Peppard RF, Martin WR, Carr GD, Grochowski E, Schulzer M, Guttman M et al (1992) Cerebral glucose metabolism in Parkinson's disease with and without dementia. Arch Neurol 49 : 1262 1268.
59. Ramirez-Ruiz B, Marti MJ, Tolosa E, Bartres-Faz D, Summerfield C, Salgado-Pineda P et al (2005) Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia. J Neurol 252 : 1345 1352.
60. Riekkinen P, Jr., Kejonen K, Laakso MP, Soininen H, Partanen K, Riekkinen M (1998) Hippocampal atrophy is related to impaired memory, but not frontal functions in non-demented Parkinson's disease patients. Neuroreport 9 : 1507 1511.
61. Rinne JO, Portin R, Ruottinen H, Nurmi E, Bergman J, Haaparanta M, Solin O (2000) Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study. Arch Neurol 57 : 470 475.
62. Sawada H, Udaka F, Kameyama M, Seriu N, Nishinaka K, Shindou K et al (1992) SPECT findings in Parkinson's disease associated with dementia. J Neurol Neurosurg Psychiatry 55 : 960 963.
63. Schacht U, Leven M (1984) Stereoselective inhibition of synaptosomal catecholamine uptake by nomifensine. Eur J Pharmacol 98 : 275 277.
64. Schapiro MB, Pietrini P, Grady CL, Ball MJ, DeCarli C, Kumar A et al (1993) Reductions in parietal and temporal cerebral metabolic rates for glucose are not specific for Alzheimer's disease. J Neurol Neurosurg Psychiatry 56 : 859 864.
65. Shimada H, Hirano S, Shinotoh H, Aotsuka A, Sato K, Tanaka N et al (2009) Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET. Neurology 73 : 273 278.
66. Summerfield C, Junque C, Tolosa E, Salgado-Pineda P, Gomez-Anson B, Marti MJ et al (2005) Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study. Arch Neurol 62 : 281 285.
67. Tachibana H, Tomino Y, Kawabata K, Sugita M, Fukuchi M (1995) Twelve-month follow-up study of regional cerebral blood flow in Parkinson's disease. Dementia 6 : 89 93.
68. Tam CWC, Burton EJ, McKeith IG, Burn DJ, O'Brien JT (2005) Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies. Neurology 64 : 861 865.
69. van Beilen M, Portman AT, Kiers HA, Maguire RP, Kaasinen V, Koning M et al (2008) Striatal FDOPA uptake and cognition in advanced non-demented Parkinson's disease: a clinical and FDOPA-PET study. Parkinsonism Relat Disord 14 : 224 228.
70. Vander Borght T, Minoshima S, Giordani B, Foster NL, Frey KA, Berent S et al (1997) Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity. J Nucl Med 38 : 797 802.
71. Villancourt D, Spraker M, Prodoehl J, Abraham I, Corcos D, Zhou X et al (2009) High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology 72 : 1378 1384.
72. Wallin A, Ekberg S, Lind K, Milos V, Granerus AK, Granerus G (2007) Posterior cortical brain dysfunction in cognitively impaired patients with Parkinson's disease - a rCBF scintigraphy study. Acta Neurol Scand 116 : 347 354.
73. Whitehouse PJ, Hedreen JC, White CL, 3rd., Price DL (1983) Basal forebrain neurons in the dementia of Parkinson disease. Ann Neurol 13 : 243 248.
74. Yong SW, Yoon JK, An YS, Lee PH (2007) A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies. Eur J Neurol 14 : 1357 1362.